Praxis Precision Medicine (PRAX) Stock Price, Quote, News & History

Comments

Praxis Precision Medicines Inc (PRAX) Stock Price, Quote, News & History

PRAXNASDAQ

Trade with Public

$315.35

-4.89-1.53%

Last update: Apr 10, 1:20 PM

OverviewNews Earnings Options Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$325.12

Close

-

Volume / Avg.

143.84K / 467.89K

Day Range

$315.00 - $326.56

52 Wk Range

26.70 - 356.00

Market Cap

$8.78B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

53

Short Interest

13.46%

Days to Cover

9.9

Recent Praxis Precision Medicines Inc News

Praxis Stock Rises After Elsunersen Shows 77% Seizure Reduction In Trial

Praxis Precision Medicines shares are trading higher Monday after it announced positive results from the EMBRAVE Part A Trial of Elsunersen.

Dylan Berman

Xenon Pharmaceuticals Rallies After Pivotal Data Shows Major Drop In Monthly Seizures

Xenon Pharmaceuticals shares surge after Phase 3 data show strong seizure reduction for azetukalner, with FDA filing planned for 2026.

Vandana Singh

Praxis Precision Medicine Analysts Raise Their Forecasts After Q4 Results

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-249.07M

Investing Cash Flow (TTM)

-311.15M

Financing Cash Flow (TTM)

702.17M

Free Cash Flow (TTM)

-249.12M

Capital Expenditure (TTM)

-56.00K

Net Change in Cash (TTM)

141.96M

Analyst Trends and Forecast

12

1

Dec 25

2

1

Jan

5

2

1

Feb

2

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$8.32B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

10.16

Earnings Yield % (TTM)

-4.21%

Earnings Yield % (FWD)

-4.38%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$31.53

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$357.33M

Debt to Equity

0.00

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$325.12

Close

-

Volume / Avg.

143.84K / 467.89K

Day Range

$315.00 - $326.56

52 Wk Range

26.70 - 356.00

Market Cap

$8.78B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

53

Short Interest

13.46%

Days to Cover

9.9

About

Sector

Health Care

Industry

Biotechnology

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excita...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Praxis Precision Medicine (PRAX) stock?

A

You can purchase shares of Praxis Precision Medicine (NASDAQ:PRAX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Praxis Precision Medicine (PRAX) competitors?

A

Other companies in Praxis Precision Medicine’s space includes: Cogent Biosciences Inc (NASDAQ:COGT), Celcuity Inc (NASDAQ:CELC), Centessa Pharmaceuticals PLC (NASDAQ:CNTA), Neurocrine Biosciences Inc (NASDAQ:NBIX) and Ionis Pharmaceuticals Inc (NASDAQ:IONS).

Q

What is the forecast, or price target, for Praxis Precision Medicine (PRAX) stock?

A

Praxis Precision Medicine has a consensus price target of $511.28.

Q

What is the current price for Praxis Precision Medicine (PRAX)?

A

The stock price for Praxis Precision Medicine (NASDAQ: PRAX) is $315.35 last updated April 10, 2026 at 1:20 PM EDT.

Q

Does Praxis Precision Medicine (PRAX) pay a dividend?

A

There are no upcoming dividends for Praxis Precision Medicine.

Q

When is Praxis Precision Medicine (NASDAQ:PRAX) reporting earnings?

A

Praxis Precision Medicine does not have any upcoming earnings scheduled.

Q

Is Praxis Precision Medicine (PRAX) going to split?

A

There is no upcoming split for Praxis Precision Medicine.

Q

What sector and industry does Praxis Precision Medicine (PRAX) operate in?

A

Praxis Precision Medicine is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

Cogent Biosciences Inc

Centessa Pharmaceuticals PLC

NASDAQ:CNTA

$39.60

-0.41%

Neurocrine Biosciences Inc

NASDAQ:NBIX

$131.60

-1.98%

Ionis Pharmaceuticals Inc

Protagonist Therapeutics Inc

NASDAQ:PTGX

$99.68

-4.23%

Arrowhead Pharmaceuticals Inc

NASDAQ:ARWR

$66.38

-1.73%

Key Statistics

Open

$325.12

Close

-

Volume / Avg.

143.84K / 467.89K

Day Range

$315.00 - $326.56

52 Wk Range

26.70 - 356.00

Market Cap

$8.78B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

53

Short Interest

13.46%

Days to Cover

9.9

Recent Praxis Precision Medicines Inc News

Praxis Stock Rises After Elsunersen Shows 77% Seizure Reduction In Trial

Praxis Precision Medicines shares are trading higher Monday after it announced positive results from the EMBRAVE Part A Trial of Elsunersen.

Dylan Berman

Xenon Pharmaceuticals Rallies After Pivotal Data Shows Major Drop In Monthly Seizures

Xenon Pharmaceuticals shares surge after Phase 3 data show strong seizure reduction for azetukalner, with FDA filing planned for 2026.

Vandana Singh

Praxis Precision Medicine Analysts Raise Their Forecasts After Q4 Results

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-249.07M

Investing Cash Flow (TTM)

-311.15M

Financing Cash Flow (TTM)

702.17M

Free Cash Flow (TTM)

-249.12M

Capital Expenditure (TTM)

-56.00K

Net Change in Cash (TTM)

141.96M

Analyst Trends and Forecast

12

1

Dec 25

2

1

Jan

5

2

1

Feb

2

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$8.32B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

10.16

Earnings Yield % (TTM)

-4.21%

Earnings Yield % (FWD)

-4.38%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$31.53

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$357.33M

Debt to Equity

0.00

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$325.12

Close

-

Volume / Avg.

143.84K / 467.89K

Day Range

$315.00 - $326.56

52 Wk Range

26.70 - 356.00

Market Cap

$8.78B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

53

Short Interest

13.46%

Days to Cover

9.9

About

Sector

Health Care

Industry

Biotechnology

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excita...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry